Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
Chadia Haddad, Pascale Salameh, Hala Sacre, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Anticholinergic Burden and Cognitive Function in Psychosis: A Systematic Review and Meta-Analysis
Valentina Mancini, Caren Latrèche, Jack B. Fanshawe, et al.
American Journal of Psychiatry (2025)
Closed Access | Times Cited: 1
Genetic overlap between schizophrenia and cognitive performance
Jianfei Zhang, Hao Qiu, Qiyu Zhao, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Examining the relationships between cognition and auditory hallucinations: A systematic review
A. Polly Bell, Wei Lin Toh, Paul Allen, et al.
Australian & New Zealand Journal of Psychiatry (2024) Vol. 58, Iss. 6, pp. 467-497
Open Access | Times Cited: 4
Antidopaminergic medications in Huntington's disease
Andrew M. Tan, Michal Geva, Y. Paul Goldberg, et al.
Journal of Huntington s Disease (2025)
Open Access
Schizophrenia Management Approaches: A Look at Progress and Challenges
Kantilal M. Patel, Terry Oroszi
World Journal of Neuroscience (2025) Vol. 15, Iss. 01, pp. 13-34
Open Access
The associations of negative and disorganization symptoms with verbal fluency in schizophrenia: the mediation effect of processing speed and cognitive flexibility
Ernest Tyburski, Ewa Zawadzka, Adrianna Bober, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
The Association Between Psychotropic Medications and Cognitive Functioning in a Real-World Cohort of 869 Individuals with Schizophrenia
Faith Dickerson, Andrea Origoni, Emily Katsafanas, et al.
Schizophrenia Bulletin (2025)
Closed Access
Antipsychotic and pharmacogenomic effects on cross-sectional symptom severity and cognitive ability in schizophrenia
Siobhan K. Lock, Djenifer B. Kappel, Michael J. Owen, et al.
EBioMedicine (2025) Vol. 116, pp. 105745-105745
Closed Access
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia
Pierluigi Selvaggi, Leonardo Fazio, Veronica Debora Toro, et al.
Schizophrenia Research (2023) Vol. 260, pp. 76-84
Open Access | Times Cited: 7
A review on side effect management of second generation antipsychotics to treat schizophrenia: a drug safety perspective
Wolfgang Strube, Elias Wagner, Jurjen J. Luykx, et al.
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 6, pp. 715-729
Closed Access | Times Cited: 2
Delirium in psychiatric settings: risk factors and assessment tools in patients with psychiatric illness: a scoping review
Cheng Zhi Huang, Bei Wu, Haiqin Chen, et al.
BMC Nursing (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Disability and Adverse Effects of Oral Versus Long-Acting Injectable Antipsychotics in Schizophrenia-Spectrum and Bipolar Disorder: A Comparison Based on Data-Driven Taxonomy
Alessandro Rodolico, Sofia Francesca Aprile, Pierfelice Cutrufelli, et al.
Clinical Drug Investigation (2024) Vol. 44, Iss. 9, pp. 715-727
Open Access | Times Cited: 2
Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophrenia
Ville Mäkipelto, Annamari Tuulio‐Henriksson, Christian Hakulinen, et al.
Schizophrenia Research (2024) Vol. 266, pp. 118-126
Open Access | Times Cited: 1
Anticholinergic load: A commonly neglected and preventable risk to cognition during schizophrenia treatment?
C. Martínez-Cao, Ainoa García-Fernández, Leticia González-Blanco, et al.
Schizophrenia Research Cognition (2024) Vol. 37, pp. 100317-100317
Open Access | Times Cited: 1
Biomarkers of cognitive and memory decline in psychotropic drug users
Monica Grigore, Mihai Andrei Ruscu, Dirk M. Hermann, et al.
Journal of Neural Transmission (2024)
Open Access | Times Cited: 1
Enhancing visual working memory in schizophrenia: effects of frontoparietal theta tACS in low-performing patients
Jiunn-Kae Wang, Prangya Parimita Sahu, Hsiao‐Lun Ku, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Effects of mindfulness-based interventions (MBIs) on psychotic symptoms and psychological outcomes in patients with schizophrenia spectrum disorders: A systematic review and meta-analysis
Chuntana Reangsing, Sathit Wongsuraprakit, Sasinun Punsuwun, et al.
Psychiatry Research (2024), pp. 116272-116272
Closed Access | Times Cited: 1
Cognitive impairment in the schizophrenia spectrum: exploring the relationships of the g-factor with sociodemography, psychopathology, neurodevelopment, and genetics
Delphine Yeh, Qin He, Emma Krebs, et al.
Psychological Medicine (2024) Vol. 54, Iss. 15, pp. 4243-4254
Open Access | Times Cited: 1
Association between cognitive function, antioxidants, and clinical variables in Chinese patients with schizophrenia
Dan Li, Yuanyuan Huang, Hongxin Lu, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Cognitive subgroups and the relationships with symptoms, psychosocial functioning and quality of life in first-episode non-affective psychosis: a cluster-analysis approach
Candice Tze Kwan Kam, Vivian Shi Cheng Fung, Wing Chung Chang, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 2
Neuropsychological function in psychosis of epilepsy
James Allebone, Richard Kanaan, Genevieve Rayner, et al.
Epilepsy Research (2023) Vol. 196, pp. 107222-107222
Open Access | Times Cited: 1
Cognitive Inflexibility Predicts Negative Symptoms Severity in Patients with First-Episode Psychosis: A 1-Year Follow-Up Study
Leonidas Mantonakis, Pentagiotissa Stefanatou, Antonis Tsionis, et al.
Brain Sciences (2024) Vol. 14, Iss. 2, pp. 162-162
Open Access
Authors' reply to the letter to the editor on “Managing geriatric syndromes: necessity of pharmacists' involvements” by Kojima
Fumihiro Mizokami, Sho Hasegawa, Tomohiro Mizuno, et al.
Geriatrics and gerontology international/Geriatrics & gerontology international (2024) Vol. 24, Iss. 4, pp. 448-450
Closed Access
Computational speech markers of negative symptoms show evidence of being robust to antipsychotic dose and extrapyramidal symptoms in schizophrenia
Michael J. Spilka, Jessica Robin, Amir Hossein Nikzad, et al.
(2024)
Open Access
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort
Nathan Vidal, Paul Roux, Mathieu Urbach, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top